SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                  SCHEDULE 13D
                                 (Rule 13d-101)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a)
             AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)
                               (Amendment No. 3)*

                                 CELLSTAR CORP.
                                ---------------
                                (Name of Issuer)

                    Common Stock, par value $0.01 per share
                    ---------------------------------------
                         (Title of Class of Securities)

                                   150925105
                                  ------------
                                 (CUSIP Number)

                                 Colin Lancaster
                                 General Counsel
                                Stark Investments
                              3600 South Lake Drive
                              St. Francis, WI 53235
                                  414-294-7000
                  (Name, Address and Telephone Number of Person
               Authorized to Receive Notices and Communications)

                                November 14, 2003
            (Date of event which requires filing of this statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d 1(e), 13d 1(f) or 13d 1(g), check the following
box [ ]

* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 (the "Exchange Act") or otherwise subject to the liabilities of that
section of the Exchange Act but shall be subject to all other provisions of the
Exchange Act (however, see the Notes).

                                                                  Page 2 of 6
_____________________________________________________________________________
     NAMES OF REPORTING PERSONS
     I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)
1
     Michael A. Roth and Brian J. Stark, as joint filers pursuant to
     Rule 13d-1(k)
_____________________________________________________________________________
2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*               (a) [ ]
                           Not Applicable                            (b) [ ]
_____________________________________________________________________________
3    SEC USE ONLY
_____________________________________________________________________________
     SOURCE OF FUNDS
4
     N/A
_____________________________________________________________________________
     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
5    PURSUANT TO ITEM 2(d) OR 2(e)                                       [ ]
_____________________________________________________________________________
6    CITIZENSHIP OR PLACE OF ORGANIZATION

     United States
_____________________________________________________________________________

NUMBER OF      7    SOLE VOTING POWER

SHARES              4,276,492 (See Item 5)
               ______________________________________________________________
BENEFICIALLY   8    SHARED VOTING POWER

OWNED BY            0
               ______________________________________________________________
EACH           9    SOLE DISPOSITIVE POWER

REPORTING           4,276,492 (See Item 5)
               ______________________________________________________________
PERSON         10   SHARED DISPOSITIVE POWER

WITH                0
_____________________________________________________________________________
     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
     4,276,492 (See Item 5)
_____________________________________________________________________________
12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
                                                                       [ ]
_____________________________________________________________________________
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     21% (See Item 5)
_____________________________________________________________________________
     TYPE OF REPORTING PERSON*
14
     IN
_____________________________________________________________________________

                                                                     Page 3 of 6

Item 1    Security and Issuer.

          This Amendment No. 3 on Schedule 13D is filed in connection with the
          shares of Common Stock, par value $0.01 per share (the "Shares"), of
          Cellstar Corp. (the "Company"), with its principal executive offices
          at 1730 Briecroft Drive, Carrolton, TX 75006. This Amendment No. 3
          hereby amends and supplements the Schedule 13D originally filed on
          March 12, 2002, as amended by Amendment No. 1 on November 5, 2003 and
          Amendment No. 2 on November 10, 2003.

Item 2.   Identity and Background.

          The business address for Messrs. Roth and Stark and the entities is
          c/o Stark Investments, 3600 South Lake Drive, St. Francis WI 53235.

Item 3.   Source and Amount of Funds or Other Consideration.

          N/A

Item 4.   Purpose of Transaction.

          The Reporting Persons intend to continue to evaluate the performance
          of its Shares as an investment in the ordinary course of business.


Item 5.   Interest in Securities of the Issuer.

          (a)(b) The Reporting Persons currently beneficially own an aggregate
          of 4,276,492 shares of Common Stock or 21% of the outstanding shares
          of Common Stock which the Company has indicated, in its Quarterly
          Report on Form 10Q for the quarterly period ended August 31, 2003, to
          be 20,354,364 shares of Common Stock.

          (c) See Exhibit A attached hereto.

          (d)(e) Not applicable.

Item 6.   Contracts, Arrangements, Understandings or Relationships with Respect
          to Securities of the Issuer.

          N/A

Item 7.   Material to be Filed as Exhibits.

          Exhibit 1 - Joint Filing Agreement.


                                                                     Page 4 of 6

                                   Signatures

     After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.

Dated:   November 24, 2003

                                        /s/ Michael A. Roth
                                        -----------------------
                                        Michael A. Roth

                                        /s/ Brian J. Stark
                                        -----------------------
                                        Brian J. Stark

                                                                     Page 5 of 6

                                                                       Exhibit 1

                             JOINT FILING AGREEMENT

     In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934,
as amended, the undersigned agree to the joint filing on behalf of each of them
of an Amendment No. 3 to Schedule 13D (including amendments thereto) with
respect to certain shares of Common Stock, $.01 par value of Cellstar Corp. and
further agree that this Joint Filing Agreement shall be included as an exhibit
to such joint filings.

     The undersigned further agree that each party hereto is responsible for the
timely filing of such Schedule 13G and any amendments thereto, and for the
completeness and accuracy of the information concerning such party contained
therein; provided, however, that no party is responsible for the completeness or
accuracy of the information concerning any other party making the filing, unless
such party knows or has reason to believe that such information is inaccurate.

     IN WITNESS WHEREOF, the parties have executed this Joint Filing Agreement
on November 24, 2003.

                                        /s/ Michael A. Roth
                                        -----------------------
                                        Michael A. Roth

                                        /s/ Brian J. Stark
                                        -----------------------
                                        Brian J. Stark

                                                                     Page 6 of 6

                                                                       Exbibit A


       QUANTITY
         SOLD     PRICE    Date of Sale     BALANCE
1.     200,000    $13.25   11/14/2003      4,295,042
2.       5,600    $13.40   11/14/2003      4,289,442
3.       6,000    $13.45   11/14/2003      4,283,442
4.       4,000    $13.46   11/14/2003      4,279,442
5.       1,500    $13.50   11/14/2003      4,277,942
6.       1,450    $13.55   11/14/2003      4,276,492